|
|
Volumn 4, Issue 5, 2003, Pages 405-411
|
|
Colorectal cancer: integrating oxaliplatin.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
FLUOROURACIL;
FOLFOX PROTOCOL;
FOLINIC ACID;
IRINOTECAN;
OXALIPLATIN;
PLATINUM COMPLEX;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
CANCER STAGING;
CLINICAL TRIAL;
COLON RESECTION;
COLORECTAL TUMOR;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
SURVIVAL;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CHEMOTHERAPY, ADJUVANT;
COLECTOMY;
COLORECTAL NEOPLASMS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
ORGANOPLATINUM COMPOUNDS;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0142244513
PISSN: 15272729
EISSN: None
Source Type: Journal
DOI: 10.1007/s11864-003-0041-8 Document Type: Review |
|
Times cited : (12)
|
|
References (16)
|
